Immune Therapy with BMRT for treatment of Autoimmune/Neurological Diseases contains multiple indicatios: e.g. Psoriasis, Thyroiditis, (Rheumatoid) Arthritis, Multiple Sclerosis, Bowel Inflammatory Diseases, Kawamoto Syndrome, Guillain-Barré-Syndrome, Borreliosis, Post-Lyme-Syndrome and many more antibody modulated diseases. 

If an indication is not mentioned here, please contact us. The range of possible treatments is growing all the time.

​

Results:

Total: 341 patients (41.7%)

Pre-treatment average: VAS 1.5 points

Post treatment average: VAS 9.2 points

1 year post treatment average: VAS 9.0 points of maximum 10 points

​​​

Conclusion:

General health condition – health improvement according to the patient's subjective perception

 

Total: 817 (100 % - all patients with various indications)

Pre-treatment average: VAS 1.4 points

Post treatment average: VAS 9.5 points

1 year post treatment average: VAS 9.2 points of maximum 10 points

​

In summary, it can be stated that longevity, health condition and patients’ personal perception of well-being improved significantly after BMRT® Ultra High Dosage Antibody Therapy in all indications described.